These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1500660)

  • 41. Efficacy of low-dose antacids in the treatment of peptic ulcers: pharmacological explanation?
    Sewing KF
    J Clin Gastroenterol; 1991; 13 Suppl 1():S134-8. PubMed ID: 1834730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
    Tytgat GN; Simoneau G
    Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of acid secretion in peptic ulcer disease.
    Feldman M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-6. PubMed ID: 7673607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Length of effectiveness of calcium-containing and calcium-free antacids. A double-blind study].
    Weingart J; Haase W; Ottenjann R
    Fortschr Med; 1977 Nov; 95(44):2681-4. PubMed ID: 21837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.
    O'Connell MB; Madden DM; Murray AM; Heaney RP; Kerzner LJ
    Am J Med; 2005 Jul; 118(7):778-81. PubMed ID: 15989913
    [No Abstract]   [Full Text] [Related]  

  • 46. [Protective effect of alkalies on ethyl alcohol-damaged gastric mucosa].
    Mach T
    Folia Med Cracov; 1989; 30(3-4):93-101. PubMed ID: 2641941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Oral antacids and anti-ulcer drugs: each one at its proper time].
    Navarro Ferrer F; Navarro Ferrer ME; Prieto Peraita M
    Rev Enferm; 2000; 23(7-8):499-503. PubMed ID: 10983155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin.
    Higgs RH; Smyth RD; Castell DO
    N Engl J Med; 1974 Sep; 291(10):486-90. PubMed ID: 4852129
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of prolonged therapy with different agents on gastric acid-peptic secretion (neutralizers, antipeptics and anticholinergics).
    Mazure PA; Cosen JN
    Acta Gastroenterol Latinoam; 1973; 5(3):117-23. PubMed ID: 4601544
    [No Abstract]   [Full Text] [Related]  

  • 52. Prostaglandins for peptic ulcer: a promise unfulfilled.
    Hawkey CJ; Walt RP
    Lancet; 1986 Nov; 2(8515):1084-7. PubMed ID: 2877235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)].
    Baur C; Becker A; Linder R; Schwan T
    Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of drugs with acid-neutralizing and acid-suppressive effect on parietal cell function and on gastrin and somatostatin cell density of the stomach].
    Arnold R; Koop H; Nesslinger A; Schwarting H
    Z Gastroenterol; 1983 Mar; 21 Suppl():104-10. PubMed ID: 6134404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
    Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
    J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adsorption of bile acids by sucralfate, antacids, and cholestyramine in vitro.
    Ståhlberg M; Jalovaara P; Laitinen S; Mokka R; Hentilä R; Järvensivu P; Kairaluoma M
    Clin Ther; 1987; 9(6):615-21. PubMed ID: 3440273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acid rebound.
    Fordtran JS
    N Engl J Med; 1968 Oct; 279(17):900-5. PubMed ID: 20617595
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of sodium bicarbonate versus aluminum-magnesium hydroxide on postprandial gastric acid in duodenal ulcer patients.
    Simmons TC; Hogan DL; Selling JA; Maxwell V; Isenberg JI
    J Clin Gastroenterol; 1986 Apr; 8(2):146-9. PubMed ID: 3018068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determination of formulation quantities for three kinds of antacid using triangle coordinates].
    Sofue M; Ueda Y; Yamamoto M; Yamasaki T; Manabe T
    Yakugaku Zasshi; 1997 Mar; 117(3):185-92. PubMed ID: 9109346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antacid dosage in peptic ulcer].
    Kanishchev PA; Bereza NM
    Ter Arkh; 1981; 53(2):24-5. PubMed ID: 7221928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.